| Structure | Chemical Name | CAS | MF |
|
ANTI-HUMAN IGE (CLONE NO GE-1) ALKALINE PHOSPHATASE
|
|
|
|
2,7-ANTHRACENEDISULFONIC ACID, 9,10-DIHYDRO-4,5-DIAMINO-9,10-DIOXO-1-H YDROXY-, D
|
73651-49-7
|
C14H8N2Na2O9S2
|
|
ANTHRAQUINONE-1,5-BIS-ANTHRANILIC ACID POTASSIUM SALT
|
|
C28H17KN2O6
|
|
|
ANTI-HUMAN CD7 TRI-COLOR(R) (R-PE-CY5 TANDEM)
|
|
|
|
|
ANTI-HUMAN CD123, PE-CY5
|
|
|
|
|
ANTI HUMAN TR-ALPHA
|
|
|
|
|
ANTI-HUMAN HLA CLASS II DP, R-PE CONJUGATE
|
|
|
|
|
ANTI-HUMAN I-TAC
|
|
|
|
|
ANTI-HUMAN V-BETA8(B)
|
|
|
|
|
ANTI-HUMAN CD15, APC
|
|
|
|
|
ANTI-HUMAN SMAD3
|
|
|
|
3-(9-ANTHRYL)-1-(2-FURYL)PROP-2-EN-1-ONE, TECH
|
|
C21H14O2
|
|
9.10-ANTHRAQUINONE SOLUTION 100UG/ML IN METHANOL 1ML
|
|
C14H8O2
|
|
|
ANTI-HUMAN IGA CY5
|
|
|
|
Anthraquinone-1,8-Disulfonic Acid
|
|
C14H8O8S2
|
|
9 10-ANTHRACENEDIYL-BIS(METHYLENE)
|
307554-62-7
|
C22H18O8
|
|
3-(9-ANTHRYL)-1-(2,4-DIMETHOXYPHENYL)PROP-2-EN-1-ONE, TECH
|
|
C25H20O3
|
|
|
ANTI-HUMAN CD235A, PE-CY5
|
|
|
|
|
ANTI-HUMAN GDNF RECEPTOR ALPHA-2 EXTRACELLULAR DOMAIN, BIOTIN
|
|
|
|
|
ANTI-HUMAN IKKA/IKK-1 (C2)
|
|
|
|
|
ANTI-HUMAN SCF
|
|
|
|
|
ANTI-HERPES VIRUS 7, HUMAN
|
|
|
|
|
ANTI-HUMAN OPG, BIOTIN
|
|
|
|
|
ANTI-HUMAN ACTIVIN A BETAA SUBUNIT, BIOTIN
|
|
|
|
|
ANTI-HUMAN IL-2 RECEPTOR A CHAIN/CD25, CLONE B-B10
|
|
|
|
anthra[9,1-bc]naphth[3,2,1-kl]acridine-5,13-dione
|
54401-87-5
|
C31H15NO2
|
|
|
Anthracene oil, acid ext.
|
91995-14-1
|
|
|
|
ANTI-HUMAN HLA CLASS II, (DR+DP+DQ), R-PE CONJUGATE
|
|
|
|
|
ANTI-HLA-DR, PERCP
|
|
|
|
|
ANTI-HUMAN LIPOPROTEIN HDL2, HDL3, APO A-1
|
|
|
|
|
ANTI-HEPATITIS C CORE PROTEIN
|
|
|
|
|
ANTI-HUMAN/MOUSE/RAT PO4-RSK3 PDK1 SITE
|
|
|
|
|
ANTI-HAIRY CELL LEUKAEMIA, HUMAN
|
|
|
|
|
ANTI-HAMSTER CYCLIN B1
|
|
|
|
|
ANTI-HUMAN BETA-TUBULIN, N-TERMINAL STRUCTURAL DOMAIN
|
|
|
|
5-(9-anthrylmethylene)-3-(4-ethylphenyl)-2-[(4-ethylphenyl)imino]-1,3-thiazolidin-4-one
|
354995-69-0
|
C34H28N2OS
|
|
(9-anthrylsulfanyl)acetic acid
|
101277-99-0
|
C16H12O2S
|
|
11-(9-anthryl)-10-benzoyl-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one
|
352691-03-3
|
C36H30N2O2
|
|
2-(9-anthrylmethylene)-5-(4-isopropylphenyl)-7-methyl-3-oxo-N-phenyl-2,3-dihydro-5H-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxamide
|
496936-21-1
|
C38H31N3O2S
|
|
5-(anthracen-9-ylmethylidene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
|
344944-69-0
|
C19H12N2O2S
|
|
9-anthracenecarbaldehyde (5,6-diphenyl-1,2,4-triazin-3-yl)hydrazone
|
353780-41-3
|
C30H21N5
|
|
5-(9-anthrylmethylene)-2-(phenylimino)-1,3-thiazolidin-4-one
|
313519-75-4
|
C24H16N2OS
|
|
1-(9-anthryl)-1,3-butanedione
|
|
C18H14O2
|
|
anthracene dihydride
|
|
C14H12
|
|
Anthracen-9-ol
|
529-86-2
|
C14H10O
|
|
anthra[1,9-cd]pyrazol-6(2H)-one,3-bromo-
|
6375-33-3
|
C14H7BrN2O
|
|
Anthraquinone-1-Sulphonic Acid Postassium Salt
|
|
C14H7KO5S
|
|
|
ANTI-HUMAN HEREGULIN ALPHA EGF DOMAIN, BIOTIN
|
|
|
|
|
ANTI-HUMAN INTEGRIN BETA7, PE-CY5
|
|
|
|
|
ANTI-HUMAN ENOS (596-610)
|
|
|
|
anthracenediol
|
|
C14H10O2
|
|
anthracenesulfonic acid
|
|
C14H10O3S
|
|
|
ANTI-HUMAN LH/FSH
|
|
|
|
Anthra(2,3-b)furo(3,2-d)furan-5,10-dione, 3a,12a-dihydro-4,6-dihydroxy -
|
30517-65-8
|
C18H10O6
|
|
9,10-Anthracenedione, 1,5-dihydroxy-3-methyl-8-((2,6,7,7a-tetrahydro-4 H-furo(3,2-c)pyran-4-yl)oxy)-
|
93513-59-8
|
C22H18O7
|
|
|
ANTI-HUMANIN (HUMAN)
|
|
|
|
|
ANTI-HUMAN MELANOMA DISCR ANTIGEN
|
|
|
|
|
ANTI-HYALURONIC ACID
|
|
|
|
9,10-ANTHRAQUINONE-2,6-DISULFONIC ACID DISODIUM SALT PURUM, ≥97.0% (HPLC)
|
|
C14H6Na2O8S2
|
|
|
ANTI-HUMAN SCD14, BIOTIN
|
|
|
|
|
ANTI-HUMAN IGA1/IGA2, AKP
|
|
|
|
|
ANTI-HLA-B7, PHYCOERYTHRIN CONJUGATE
|
|
|
|
|
ANTI-HUMAN CD42B, PE-CY5
|
|
|
|
|
ANTI-HLA-DR
|
|
|
|
|
ANTI-HUMAN HEREGULIN BETA1 EXTRACELLULAR DOMAIN, BIOTIN
|
|
|
|
|
ANTI-HSV-1 AND 2 GLYCOPROTEIN D
|
|
|
|
|
Anti-H-VEGF(Biotinylated)
|
|
|
|
|
ANTI-HUMAN CYTOKERATIN 8 (52.5 KD) FLUORESCEIN (FITC) LABELED
|
|
|
|
|
ANTI-HPL
|
|
|
|
3-(9-ANTHRYL)-1-(4-FLUOROPHENYL)PROP-2-EN-1-ONE, TECH
|
|
C23H15FO
|
|
|
ANTI-HUMAN IGF BINDING PROTEIN-6
|
|
|
|
Anthraquinone-1,5-Difulfonic Acid
|
|
C14H8O8S2
|
|
anthraquinone-1,8-disulfonic acid dipotassium
|
|
C14H6K2O8S2
|
|
|
ANTI-HUMAN DP-1
|
|
|
|
|
ANTI-HUMAN ACTIVIN RIA EXTRACELLULAR DOMAIN
|
|
|
|
|
ANTI-HUMAN LECT2
|
|
|
|
|
ANTI-HSV-1 GLYCOPROTEIN G-1
|
|
|
|
|
ANTI-HUMAN CD45RA R-PE/CY5 CONJUGATE
|
|
|
|
|
ANTI-HUMAN MACROPHAGE STIMULATING PROTEIN BETA CHAIN
|
|
|
|
|
ANTI-HUMAN IL-16 FITC
|
|
|
|
|
ANTI-HUMAN IGA TRITC
|
|
|
|
|
ANTI-HIV-1 GAG P17 ANTIGEN
|
|
|
|
|
ANTI HUMAN REVERB-BETA
|
|
|
|
|
ANTI-HUMAN FIBRONECTIN HRP CONJUGATED
|
|
|
|
|
ANTI-HTNF RECEPTOR-ASSOCIATED FACTOR 2 (TRAF 2)
|
|
|
|
|
ANTI-HUMAN IL-10 R-BETA EXTRACELLULAR DOMAIN
|
|
|
|
|
ANTI-HUMAN IL-1ALPHA, PE
|
|
|
|
|
ANTI-HUMAN CD41A, APC
|
|
|
|
|
ANTI-HUMAN MATRIX METALLOPROTEINASE 3, BIOTIN
|
|
|
|
|
ANTI-HUMAN PROTEOGLYCAN DI OS
|
|
|
|
|
ANTI-HUMAN AUTOIMMUNE ANTIGEN RO60 (SS-A) PROTEIN
|
|
|
|
|
ANTI-HUMAN EPHA1 EXTRACELLULAR DOMAIN
|
|
|
|
|
ANTI-HUMAN CD50
|
|
|
|
9-anthracenecarbaldehyde [2,6-di(1-azepanyl)-4-pyrimidinyl]hydrazone
|
345615-44-3
|
C31H36N6
|
|
6-[2-(9-anthrylmethylene)hydrazino]-N-butyl-6-oxohexanamide
|
|
C25H29N3O2
|
|
|
ANTI-HUMAN IGD (DELTA CHAIN SPECIFIC)*DE VELOPED IN
|
|
|
|
2-Anthracenesulfonic acid, 1-amino-4-[[3- [[4-chloro-6-[(3-sulfophenyl)amino] -1,3,5-triazin-2-yl]amino]-4-sulfophenyl]amino]-9,10-dihydro-9,10-dioxo-, monolithiumdisodium salt
|
94411-87-7
|
|
|
|
ANTI-HUMAN SODD (NT)
|
|
|
|
anthracene-1-carbonitrile
|
28805-75-6
|
C15H9N
|
|
1-(anthracen-9-yl)-2,2,2-trifluoroethanethione
|
|
C16H9F3S
|